KIF20A and colorectal cancer: Understanding this interaction not only sheds light on the molecular underpinnings of colorectal cancer but also opens the door for developing targeted therapies that could inhibit the JAK/STAT3 pathway, KIF20A expression, or both, offering hope for more effective treatments for this challenging disease.